Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 2
2004 1
2005 5
2006 5
2007 3
2008 12
2009 11
2010 8
2011 5
2012 5
2013 4
2014 4
2015 4
2016 7
2017 7
2018 8
2019 5
2020 8
2021 4
2022 4
2023 4
2024 7
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Management of proteinuria: blockade of the renin-angiotensin-aldosterone system.
Athavale A, Roberts DM. Athavale A, et al. Aust Prescr. 2020 Aug;43(4):121-125. doi: 10.18773/austprescr.2020.021. Epub 2020 Aug 3. Aust Prescr. 2020. PMID: 32921887 Free PMC article. Review.
Current treatment guidelines for albuminuria recommend a single renin-angiotensin-aldosterone inhibitor. This can be an ACE inhibitor or an angiotensin receptor antagonist. The routine use of combined renin-angiotensin-aldosterone …
Current treatment guidelines for albuminuria recommend a single renin-angiotensin-aldosterone inhibitor. This can be an …
IgA nephropathy in adults-treatment standard.
Gleeson PJ, O'Shaughnessy MM, Barratt J. Gleeson PJ, et al. Nephrol Dial Transplant. 2023 Oct 31;38(11):2464-2473. doi: 10.1093/ndt/gfad146. Nephrol Dial Transplant. 2023. PMID: 37418237 Free PMC article. Review.
MEST-C score) have also been shown to independently predict outcome. Proteinuria and blood pressure are the main modifiable risk factors for disease progression. ...Optimized supportive care with lifestyle interventions and non-immunomodulatory drugs remains the bac …
MEST-C score) have also been shown to independently predict outcome. Proteinuria and blood pressure are the main modifiable risk fact …
Update of pathophysiology and management of diabetic kidney disease.
Lin YC, Chang YH, Yang SY, Wu KD, Chu TS. Lin YC, et al. J Formos Med Assoc. 2018 Aug;117(8):662-675. doi: 10.1016/j.jfma.2018.02.007. Epub 2018 Mar 2. J Formos Med Assoc. 2018. PMID: 29486908 Free article. Review.
Diabetic kidney disease (DKD) is a major cause of morbidity and mortality in patients with diabetes mellitus and the leading cause of end-stage renal disease in the world. The most characteristic marker of DKD is albuminuria, which is associated with renal diseas …
Diabetic kidney disease (DKD) is a major cause of morbidity and mortality in patients with diabetes mellitus and the leading cause of …
Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, Ku E. Weir MR, et al. Am J Kidney Dis. 2018 Dec;72(6):873-884. doi: 10.1053/j.ajkd.2018.06.010. Epub 2018 Sep 7. Am J Kidney Dis. 2018. PMID: 30201547 Review.
Multiple clinical trials have demonstrated that renin-angiotensin system (RAS) blockade with either angiotensin-converting enzyme inhibitors or angiotensin receptor blockers effectively reduces chronic kidney disease (CKD) progress …
Multiple clinical trials have demonstrated that renin-angiotensin system (RAS) blockade with either angiotens …
Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021.
Banerjee D, Winocour P, Chowdhury TA, De P, Wahba M, Montero R, Fogarty D, Frankel AH, Karalliedde J, Mark PB, Patel DC, Pokrajac A, Sharif A, Zac-Varghese S, Bain S, Dasgupta I; Association of British Clinical Diabetologists and The Renal Association. Banerjee D, et al. BMC Nephrol. 2022 Jan 3;23(1):9. doi: 10.1186/s12882-021-02587-5. BMC Nephrol. 2022. PMID: 34979961 Free PMC article.
People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor in people with diabetes for development of albuminuria, impaired kidney function, end-sta …
People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney disease (CKD) and end-stage kidney failur …
Renin-Angiotensin-Aldosterone system blockade in diabetic kidney disease: A critical and contrarian point of view.
Elrggal ME, Ahmed SM, El Nahas M. Elrggal ME, et al. Saudi J Kidney Dis Transpl. 2016 Nov-Dec;27(6):1103-1113. doi: 10.4103/1319-2442.194583. Saudi J Kidney Dis Transpl. 2016. PMID: 27900954 Review.
Diabetes mellitus is the most common cause of end-stage renal disease (ESRD) worldwide. Diabetic kidney disease (DKD) is associated with high morbidity and cardiovascular mortality. A number of guidelines and recommendations have been issued over the years recommend …
Diabetes mellitus is the most common cause of end-stage renal disease (ESRD) worldwide. Diabetic kidney disease (DKD) is assoc …
Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Hsu CY, Liu KD, Yang J, Glidden DV, Tan TC, Pravoverov L, Zheng S, Go AS. Hsu CY, et al. Clin J Am Soc Nephrol. 2020 Jan 7;15(1):26-34. doi: 10.2215/CJN.05800519. Epub 2019 Dec 16. Clin J Am Soc Nephrol. 2020. PMID: 31843974 Free PMC article.
BACKGROUND AND OBJECTIVES: How to best medically manage patients who survived hospitalized AKI is unclear. Use of renin-angiotensin system blockers in this setting may increase risk of recurrent AKI. ...All study participants did not have prior heart f …
BACKGROUND AND OBJECTIVES: How to best medically manage patients who survived hospitalized AKI is unclear. Use of renin-ang …
Management of Renin-Angiotensin-Aldosterone System Blockade in Kidney Transplant Recipients.
Heleniak Z, Kuźmiuk-Glembin I, Adrych D, Garnier H, Wiśniewski J, Rutkowski P, Rutkowski B, Tylicki L, Dębska-Ślizień A. Heleniak Z, et al. Transplant Proc. 2018 Jul-Aug;50(6):1842-1846. doi: 10.1016/j.transproceed.2018.03.027. Epub 2018 Mar 15. Transplant Proc. 2018. PMID: 30056912
A total of 391 KTRs (44.7%) using ARBs or ACEIs were qualified for the study. The primary reasons for renin-angiotensin-aldosterone system antagonist administration were hypertension (59.1%), polycythemia (19.2%), and proteinuria (18.2%). …
A total of 391 KTRs (44.7%) using ARBs or ACEIs were qualified for the study. The primary reasons for renin-angiotensin-ald …
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria.
Nakhleh A, Abdul-Ghani M, Gazit S, Gross A, Livnat I, Greenbloom M, Yarden A, Khazim K, Shehadeh N, Melzer Cohen C. Nakhleh A, et al. Diabetes Obes Metab. 2024 Aug;26(8):3058-3067. doi: 10.1111/dom.15623. Epub 2024 Apr 28. Diabetes Obes Metab. 2024. PMID: 38680053
AIM: To examine the renal effects of sodium-glucose cotransporter-2 (SGLT2) inhibition among non-diabetic individuals with chronic kidney disease (CKD) in a real-world setting. METHODS: We collected de-identified data on adults without diabetes and with an estimated glomer …
AIM: To examine the renal effects of sodium-glucose cotransporter-2 (SGLT2) inhibition among non-diabetic individuals with chronic kidney …
Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.
Bomback AS, Toto R. Bomback AS, et al. Am J Hypertens. 2009 Oct;22(10):1032-40. doi: 10.1038/ajh.2009.138. Epub 2009 Aug 6. Am J Hypertens. 2009. PMID: 19661925 Review.
The renin-angiotensin-aldosterone system (RAAS), an important regulator of blood pressure as well as fluid and electrolyte balance, plays an important role in the pathophysiology of cardiovascular and kidney diseases. Blockade of the RAAS with …
The renin-angiotensin-aldosterone system (RAAS), an important regulator of blood pressure as well as fluid and e …
115 results